TP53 MUTATIONS AND DEL17P13 PREDICT SIMILAR OUTCOME AND CHEMOREFRACTORINESS IN CHRONIC LYMPHOCYTIC LEUKEMIA

被引：0
|
作者：
Cerri, M. [1 ]
Deambrogi, C. [1 ]
Capello, D. [1 ]
Cresta, S. [1 ]
Rasi, S. [1 ]
Sozzi, E. [2 ]
De Paoli, L. [1 ]
Gattei, V. [3 ]
Forconi, F. [2 ]
Gaidano, G. [1 ]
Rossi, D. [1 ]
机构：
[1] Amedeo Avogadro Univ, Div Hematol, Novara, Italy
[2] Univ Siena, Div Hematol & Bone Marrow Transplantat, I-53100 Siena, Italy
[3] CRO, Clin & Expt Oncohematol Unit, Aviano, Italy
来源：
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL | 2008年 / 93卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
0410
引用
收藏
页码：163 / 164
页数：2
相关论文
共 50 条
  • [1] TP53 MUTATIONS AND DEL17P13 PREDICT SIMILAR OUTCOME AND CHEMOREFRACTORINESS IN CHRONIC LYMPHOCYTIC LEUKEMIA
    Rossi, D.
    Cerri, M.
    Forconi, F.
    Deambrogi, C.
    Sozzi, E.
    Cresta, S.
    Rasi, S.
    Tassi, M.
    De Paoli, L.
    Raspadori, D.
    Capello, D.
    Gattei, V
    Lauria, F.
    Gaidano, G.
    HAEMATOLOGICA, 2008, 93 : S91 - S92
  • [2] The Prognostic Value of TP53 Mutations in Chronic Lymphocytic Leukemia Is Independent of Del17p13: Implications for Overall Survival and Chemorefractoriness
    Rossi, Davide
    Cerri, Michaela
    Deambrogi, Clara
    Sozzi, Elisa
    Cresta, Stefania
    Rasi, Silvia
    De Paoli, Lorenzo
    Spina, Valeria
    Gattei, Valter
    Capello, Daniela
    Forconi, Francesco
    Lauria, Francesco
    Gaidano, Gianluca
    CLINICAL CANCER RESEARCH, 2009, 15 (03) : 995 - 1004
  • [3] The Prognostic Value of TP53 Mutations in Chronic Lymphocytic Leukemia (CLL) Is Independent of del17p13: Implications for Overall Survival and Chemorefractoriness
    Rossi, Davide
    Cerri, Michaela
    Deambrogi, Clara
    Sozzi, Elisa
    Cresta, Stefania
    Rasi, Silvia
    De Paoli, Lorenzo
    Capello, Daniela
    Gattei, Valter
    Forconi, Francesco
    Lauria, Francesco
    Gaidano, Gianluca
    BLOOD, 2008, 112 (11) : 1075 - 1075
  • [4] The prognostic significance of TP53 mutations in Chinese patients with chronic lymphocytic leukemia is independent of del(17p13)
    Dong, Hua-Jie
    Zhou, Li-Tao
    Zhu, Dan-Xia
    Wang, Dong-Mei
    Fang, Cheng
    Zhu, Hua-Yuan
    Zhuang, Yun
    Miao, Kou-Rong
    Xu, Wei
    Li, Jian-Yong
    ANNALS OF HEMATOLOGY, 2011, 90 (06) : 709 - 717
  • [5] The prognostic significance of TP53 mutations in Chinese patients with chronic lymphocytic leukemia is independent of del(17p13)
    Hua-Jie Dong
    Li-Tao Zhou
    Dan-Xia Zhu
    Dong-Mei Wang
    Cheng Fang
    Hua-Yuan Zhu
    Yun Zhuang
    Kou-Rong Miao
    Wei Xu
    Jian-Yong Li
    Annals of Hematology, 2011, 90 : 709 - 717
  • [6] TP53 Mutations and Clinical Outcome in Chronic Lymphocytic Leukemia: Is a Threshold Still Needed?
    Bomben, Riccardo
    Zucchetto, Antonella
    Pozzo, Federico
    Tissino, Erika
    Bittolo, Tamara
    Olivieri, Jacopo
    Chiarenza, Annalisa
    Zaja, Francesco
    Del Principe, Maria Ilaria
    Rossi, Davide
    Gattei, Valter
    HEMASPHERE, 2023, 7 (04):
  • [7] The TP53 Codon72 Polymorphism Is Associated with TP53 Mutations in Chronic Lymphocytic Leukemia
    Grossmann, Vera
    Artusi, Valentina
    Schnittger, Susanne
    Dicker, Frank
    Jeromin, Sabine
    Boeck, Lucia
    Haferlach, Torsten
    Haferlach, Claudia
    Kern, Wolfgang
    Kohlmann, Alexander
    BLOOD, 2011, 118 (21) : 778 - 778
  • [8] Selection of new TP53 mutations by therapy in chronic lymphocytic leukemia
    Trbusek, Martin
    Malcikova, Jitka
    Mayer, Jiri
    LEUKEMIA RESEARCH, 2011, 35 (07) : 981 - 982
  • [9] TP53 Mutations are infrequent in newly diagnosed chronic lymphocytic leukemia
    Zainuddin, Norafiza
    Murray, Fiona
    Kanduri, Meena
    Gunnarsson, Rebeqa
    Smedby, Karin E.
    Enblad, Gunilla
    Jurlander, Jesper
    Juliusson, Gunnar
    Rosenquist, Richard
    LEUKEMIA RESEARCH, 2011, 35 (02) : 272 - 274
  • [10] TP53 Aberrations in Chronic Lymphocytic Leukemia
    Trbusek, Martin
    Malcikova, Jitka
    ADVANCES IN CHRONIC LYMPHOCYTIC LEUKEMIA, 2013, 792 : 109 - 131
12345